Global /South Korea /Healthcare /Medical Distribution /109960

APTOCROM Inc.

109960

• KRX: 109960 • Delayed

1,839KRW -9%

1.21 USD

As of 14 June 2026, APTOCROM Inc. has a market cap of $23.52M USD, ranking #35946 globally and #2262 in South Korea. It ranks #3232 in the Healthcare sector, and #144 in the Medical Distribution industry.

Global Rank

35946

Country Rank

2262

Sector Rank

3232

Industry Rank

144

Key Stats

Market Cap

$23.52MUSD

35.76B KRW

Enterprise Value

$12.22MUSD

18.55B KRW

Revenue (TTM)

$6.45MUSD

9.81B KRW

EBITDA (TTM)

-$10.78MUSD

-16.37B KRW

Net Income (TTM)

-$3.66MUSD

-5.56B KRW

EBITDA Margin

-167%

Profit Margin

-57%

PS Ratio

3.6

PB Ratio

0.1

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Medical Distribution

CEO

Hui Chang open_in_new

Employees

Founded

1998

Website

aprogen-hng.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-9%	9.2%	5.3%	-30%	-42%	-29%	-53%	-88%	-95%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	109960 (주)에이프로젠헬스케어앤게임즈 ISIN: KR7109960005 Shares Out.: Shares Outstanding: 11.038M¹ Shares Float: 2.153M² TV: TradingView: KRX: 109960 SA: Stock Analysis: KRX: 109960 YF: Yahoo Finance: 109960.KS GF: Google Finance: KRX: 109960 BA: Barron's: 109960 MS: Morningstar: XKRX: 109960	1,839 KRW	TV: TradingView: KRX: 109960 SA: Stock Analysis: KRX: 109960 YF: Yahoo Finance: 109960.KS GF: Google Finance: KRX: 109960 BA: Barron's: 109960 MS: Morningstar: XKRX: 109960

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About APTOCROM Inc.

APTOCROM Inc. distributes pharmaceutical products in South Korea. It operates through pharmaceutical business, leasing business, and insulation divisions. The company is involved in design, manufacturing, and construction of insulation; design, manufacturing and installation of removable insulation materials; design, production, and construction of nuclear power plant special insulation; and foam glass insulation material molding and construction. It also offers medicines for the digestive system, including ijilong solution, gabespan soft capsule, etc.; and medicines for external skin, including lavender cream, barclax ointment, etc. In addition, the company is involved in real estate leasing, including office, laboratory, etc.; leasing business of pharmaceutical products; and equipment leasing. The company was formerly known as AP Healthcare Inc. and changed its name to APTOCROM Inc. in September 2025. APTOCROM Inc. was founded in 1998 and is headquartered in Seongnam-si, South Korea.

Similar Companies

Industry: Medical Distribution (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Hanmi Science Co., Ltd. KRX: 008930	$1.69B 2.57T KRW 7K%	21.8	South Korea
HLB Life Science Co., Ltd. KRX: 067630	$344.12M 523.33B KRW 1K%	-	South Korea
HLB Therapeutics Co.,Ltd. KRX: 115450	$214.85M 326.75B KRW 814%	-	South Korea
Manyo Factory Co., Ltd. KRX: 439090	$180.98M 275.24B KRW 670%	30.1	South Korea
Ensol Biosciences, Inc. KRX: 140610	$114.89M 174.72B KRW 389%	-	South Korea
Aminologics Co.,Ltd. KRX: 074430	$83.39M 126.82B KRW 255%	36.1	South Korea

Industry: Medical Distribution (Global)

Name	Market Cap (USD) diff.	PE	Country
McKesson Corp. NYSE: MCK	$100.76B 428K%	24.0	United States
Cencora, Inc. NYSE: COR	$60.58B 258K%	37.4	United States
Cardinal Health, Inc. NYSE: CAH	$47.73B 203K%	29.6	United States
Henry Schein, Inc. NASDAQ: HSIC	$8.47B 36K%	22.6	United States
Sinopharm Group Co. Ltd. SHEK: 1099	$7.48B 58.61B HKD 32K%	7.2	China
Galenica AG SIX: GALE	$5.27B 4.2B CHF 22K%	23.0	Switzerland

chevron_leftBack